Paul Long
Vascular Surgery · Bend, ORNPI 1972820355
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Silk Road Medical, Inc. accounts for 76.3% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2021 at $24,123 and has fallen 82.0% since, to $4,343 in 2025. Among vascular surgery clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 337 payments — averaging $185.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Silk Road Medical, Inc.$48K
- Angiodynamics, Inc.$3K
- Boston Scientific$3K
- Penumbra, Inc.$3K
- Medtronic$1K
- W. L. Gore & Associates, Inc.$1K
- plus $3K from 20 others
What the payments were for
- Consulting fees$34,90356%
- Travel & lodging$9,83216%
- Food & beverage$14,45923%
- Education$3,2265%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Silk Road Medical, Inc. | 146 | $47,627 |
| Angiodynamics, Inc. | 2 | $3,241 |
| Boston Scientific | 74 | $3,046 |
| Penumbra, Inc. | 14 | $2,919 |
| Medtronic(2 entities) | 21 | $1,277 |
| W. L. Gore & Associates, Inc. | 14 | $1,130 |
| Cook Medical LLC | 20 | $908 |
| Endologix LLC | 9 | $745 |
| Johnson & Johnson | 14 | $405 |
| Shockwave Medical, Inc | 4 | $199 |
| Cagent Vascular Inc | 1 | $158 |
| Shape Memory Medical Inc. | 1 | $150 |
| Bard Peripheral Vascular, Inc. | 1 | $123 |
| Bolton Medical Inc | 1 | $84 |
| Cardiva Medical, Inc. | 3 | $65 |
| BD | 1 | $59 |
| Inari Medical, Inc. | 1 | $58 |
| Reflow Medical Inc | 1 | $37 |
| Asahi Intecc USA, Inc. | 1 | $36 |
| Nevro Corp. | 1 | $26 |
| Biowound Solutions, Inc. | 1 | $25 |
| Abbott | 1 | $24 |
| Acera Surgical, Inc. | 1 | $23 |
| Teleflex LLC | 1 | $19 |
| Lemaitre Vascular, Inc. | 2 | $17 |
| Surmodics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$45,581
- ENHANCE Transcarotid Peripheral Access Kit$34,562
- ENROUTE Transcarotid Stent$29,428
- ENROUTE .014 Guidewire$18,607
- ENROUTE Transcarotid Stent System$15,955
- ENROUTE 0.014 Guidewire$15,955
- Auryon Laser System 100-120 Vac$3,188
- Indigo System$2,311
- Endurant$499
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$470
- Penumbra System$398
- GORE EXCLUDER AAA Endoprosthesis$175
- ENDURANT IIS$167
- ALTO$158
- Serrantor$158
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$150
- IMPEDE EMBOLIZATION PLUG$150
- GENERAL VASCULAR INTERVENTION$149
- Cook$145
- ELUVIA$145
How this compares
$62,419 in reported general payments places this provider in the 90th percentile of 56 vascular surgery providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 37 | $47,301 |
| EliquisApixaban | 20 | $31,501 |
| ClopidogrelClopidogrel Bisulfate | 297 | $4,454 |
| Cilostazol | 39 | $898 |
| Atorvastatin Calcium | 53 | $839 |
| Gabapentin | 20 | $229 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $405 | $47,30137 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 56 vascular surgery providers in Oregon.
Other vascular surgery in Bend
- Wayne NelsonBend$69K
- Jason JundtBend$15K
- James BallardBend$15K
- John WiestBend$2K
- Brant UlleryWilsonville$816K
- Mark MoraschSpringfield$127K
- Cherrie AbrahamPortland$80K
- Jeffrey CrawfordCorvallis$46K
- Craig SeidmanSpringfield$20K
- John DusselWilsonville$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.